BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yasutake K, Kohjima M, Kotoh K, Nakashima M, Nakamuta M, Enjoji M. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(7): 1756-1767 [PMID: 24587653 DOI: 10.3748/wjg.v20.i7.1756] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Mansour A, Hekmatdoost A, Mirmiran P. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease? J Dig Dis 2019;20:271-7. [DOI: 10.1111/1751-2980.12751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Vega-badillo J. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICA. TIP 2017;20:50-65. [DOI: 10.1016/j.recqb.2016.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Patanwala I, Molnar LE, Akerboom K, Lane KE. Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with non-alcoholic fatty liver disease. Frontline Gastroenterol 2021;12:557-63. [PMID: 34917312 DOI: 10.1136/flgastro-2020-101669] [Reference Citation Analysis]
4 Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019;11:E3008. [PMID: 31835303 DOI: 10.3390/nu11123008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Imran M, Sergent O, Tête A, Gallais I, Chevanne M, Lagadic-Gossmann D, Podechard N. Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae. Biomolecules 2018;8:E26. [PMID: 29757947 DOI: 10.3390/biom8020026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rosado CP, Rosa VHC, Martins BC, Soares AC, Santos IB, Monteiro EB, Moura-nunes N, da Costa CA, Mulder ADRP, Daleprane JB. Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in mice. International Journal of Biological Macromolecules 2020;145:1066-72. [DOI: 10.1016/j.ijbiomac.2019.09.199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
7 Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study. Open Access Maced J Med Sci 2019;7:3313-8. [PMID: 31949537 DOI: 10.3889/oamjms.2019.647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 León-Plascencia M, Larrosa-Haro A, Romero-Velarde E, Bravo-Núñez EC, López-Marure E. Dietary and sociodemographic factors associated with nonalcoholic fatty liver in obese pediatric patients. Rev Gastroenterol Mex (Engl Ed) 2021;86:236-43. [PMID: 34210457 DOI: 10.1016/j.rgmxen.2021.05.005] [Reference Citation Analysis]
9 Monserrat-Mesquida M, Quetglas-Llabrés M, Abbate M, Montemayor S, Mascaró CM, Casares M, Tejada S, Abete I, Zulet MA, Tur JA, Martínez JA, Sureda A. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel) 2020;9:E759. [PMID: 32824349 DOI: 10.3390/antiox9080759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sales RC, Medeiros PC, Spreafico F, de Velasco PC, Gonçalves FKA, Martín-Hernández R, Mantilla-Escalante DC, Gil-Zamorano J, Peres WAF, de Souza SAL, Dávalos A, Tavares do Carmo MG. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet. Int J Mol Sci 2018;20:E8. [PMID: 30577497 DOI: 10.3390/ijms20010008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hsiao CC, Teng PH, Wu YJ, Shen YW, Mar GY, Wu FZ. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis. BMC Cardiovasc Disord 2021;21:244. [PMID: 34011282 DOI: 10.1186/s12872-021-02060-z] [Reference Citation Analysis]
12 Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Liu C. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol 2015; 21(5): 1650-1662 [PMID: 25663786 DOI: 10.3748/wjg.v21.i5.1650] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
13 Federico A, Zulli C, de Sio I, Del Prete A, Dallio M, Masarone M, Loguercio C. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(45): 16841-16857 [PMID: 25492998 DOI: 10.3748/wjg.v20.i45.16841] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
14 Kurosaka Y, Shiroya Y, Yamauchi H, Kitamura H, Minato K. Characterization of fat metabolism in the fatty liver caused by a high-fat, low-carbohydrate diet: A study under equal energy conditions. Biochemical and Biophysical Research Communications 2017;487:41-6. [DOI: 10.1016/j.bbrc.2017.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Song L, Zhao XG, Ouyang PL, Guan Q, Yang L, Peng F, Du H, Yin F, Yan W, Yu WJ, Yan H. Combined effect of n -3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial. Br J Nutr 2020;123:1148-58. [DOI: 10.1017/s0007114520000495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lambertz J, Berger T, Mak TW, van Helden J, Weiskirchen R. Lipocalin-2 in Fructose-Induced Fatty Liver Disease. Front Physiol 2017;8:964. [PMID: 29234288 DOI: 10.3389/fphys.2017.00964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kaikkonen JE, Würtz P, Suomela E, Lehtovirta M, Kangas AJ, Jula A, Mikkilä V, Viikari JS, Juonala M, Rönnemaa T, Hutri-Kähönen N, Kähönen M, Lehtimäki T, Soininen P, Ala-Korpela M, Raitakari OT. Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study. Hepatology 2017;65:491-500. [PMID: 27775848 DOI: 10.1002/hep.28899] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
18 Ahowesso C, Black PN, Saini N, Montefusco D, Chekal J, Malosh C, Lindsley CW, Stauffer SR, DiRusso CC. Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death. Biochem Pharmacol 2015;98:167-81. [PMID: 26394026 DOI: 10.1016/j.bcp.2015.09.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
19 Green CJ, Hodson L. The influence of dietary fat on liver fat accumulation. Nutrients 2014;6:5018-33. [PMID: 25389901 DOI: 10.3390/nu6115018] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
20 Kronenfeld JP, Goel N. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1209-19. [PMID: 34611524 DOI: 10.2147/JHC.S284430] [Reference Citation Analysis]
21 Saini N, Black PN, Montefusco D, DiRusso CC. Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity. Biochem Biophys Res Commun 2015;465:534-41. [PMID: 26284975 DOI: 10.1016/j.bbrc.2015.08.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cansanção K, Citelli M, Carvalho Leite N, López de Las Hazas MC, Dávalos A, Tavares do Carmo MDG, Peres WAF. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial. Nutrients 2020;12:E3372. [PMID: 33147705 DOI: 10.3390/nu12113372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kwak JH, Jun DW, Lee SM, Cho YK, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. Clin Nutr. 2018;37:1550-1557. [PMID: 28918170 DOI: 10.1016/j.clnu.2017.08.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
24 Wu KT, Kuo PL, Su SB, Chen YY, Yeh ML, Huang CI, Yang JF, Lin CI, Hsieh MH, Hsieh MY, Huang CF, Lin WY, Yu ML, Dai CY, Wang HY. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. J Clin Lipidol 2016;10:420-5.e1. [PMID: 27055973 DOI: 10.1016/j.jacl.2015.12.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
25 Simón J, Casado-Andrés M, Goikoetxea-Usandizaga N, Serrano-Maciá M, Martínez-Chantar ML. Nutraceutical Properties of Polyphenols against Liver Diseases. Nutrients 2020;12:E3517. [PMID: 33203174 DOI: 10.3390/nu12113517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Maciejewska D, Marlicz W, Ryterska K, Banaszczak M, Jamioł-Milc D, Stachowska E. Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD). Can J Gastroenterol Hepatol 2018;2018:5856201. [PMID: 30631760 DOI: 10.1155/2018/5856201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 Abuqwider JN, Mauriello G, Altamimi M. Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review. Microorganisms 2021;9:1098. [PMID: 34065217 DOI: 10.3390/microorganisms9051098] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Panera N, Della Corte C, Crudele A, Stronati L, Nobili V, Alisi A. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines. Expert Review of Gastroenterology & Hepatology 2015;10:393-403. [DOI: 10.1586/17474124.2016.1110485] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
29 Açıkel Elmas M, Atay N, Bingöl Özakpınar Ö, Arbak S, Kolgazi M, Şener G, Ercan F. Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats. Turk J Gastroenterol 2020;31:626-32. [PMID: 33090099 DOI: 10.5152/tjg.2020.19638] [Reference Citation Analysis]
30 Federico A, Dallio M, Caprio GG, Gravina AG, Picascia D, Masarone M, Persico M, Loguercio C. Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. Nutrients 2017;9:E1074. [PMID: 28956816 DOI: 10.3390/nu9101074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
31 Arora C, Malhotra A, Ranjan P, Vikram NK, Shalimar, Singh N, Dwivedi SN. Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings. Cureus 2019;11:e5999. [PMID: 31808444 DOI: 10.7759/cureus.5999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Green CJ, Pramfalk C, Morten KJ, Hodson L. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab 2015;308:E1-20. [PMID: 25352434 DOI: 10.1152/ajpendo.00192.2014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
33 Asai Y, Yamada T, Tsukita S, Takahashi K, Maekawa M, Honma M, Ikeda M, Murakami K, Munakata Y, Shirai Y, Kodama S, Sugisawa T, Chiba Y, Kondo Y, Kaneko K, Uno K, Sawada S, Imai J, Nakamura Y, Yamaguchi H, Tanaka K, Sasano H, Mano N, Ueno Y, Shimosegawa T, Katagiri H. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. Gastroenterology 2017;152:1521-1535.e8. [PMID: 28088462 DOI: 10.1053/j.gastro.2017.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
34 Ali Z, Saeed IM, Bybee KA, Thompson R, O'Keefe JH, Shafiq M, Saeed L, Zafar Y, Kennedy KF, Al-Sayyed L. Correlation of Hepatic Steatosis Among Cohabitants Using Hounsfield Unit From Coronary Computed Tomography. Cureus 2021;13:e17834. [PMID: 34660042 DOI: 10.7759/cureus.17834] [Reference Citation Analysis]
35 Zhang X, Goh GB, Chan W, Wong GL, Fan J, Seto W, Huang Y, Lin H, Lee I, Lee HW, Kim SU, Chow WC, Wong VW, Petta S. Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease. Liver Int 2020;40:2719-31. [DOI: 10.1111/liv.14638] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
37 Lee MR, Lim YH, Lee BE, Hong YC. Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study. Environ Health 2017;16:17. [PMID: 28257627 DOI: 10.1186/s12940-017-0228-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
38 Kamada Y, Hashimoto R, Yamamori H, Yasuda Y, Takehara T, Fujita Y, Hashimoto K, Miyoshi E. Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects. BBA Clin 2016;5:101-7. [PMID: 27051595 DOI: 10.1016/j.bbacli.2016.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
39 Takada I, Makishima M. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).Expert Opin Ther Pat. 2020;30:1-13. [PMID: 31825687 DOI: 10.1080/13543776.2020.1703952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
40 Jamka M, Arslanow A, Bohner A, Krawczyk M, Weber S, Grünhage F, Lammert F, Stokes C. Effects of Gene Variants Controlling Vitamin D Metabolism and Serum Levels on Hepatic Steatosis. Digestion 2018;97:298-308. [DOI: 10.1159/000485180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
41 Endo-Umeda K, Nakashima H, Umeda N, Seki S, Makishima M. Dysregulation of Kupffer Cells/Macrophages and Natural Killer T Cells in Steatohepatitis in LXRα Knockout Male Mice. Endocrinology 2018;159:1419-32. [PMID: 29409022 DOI: 10.1210/en.2017-03141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
42 Tutunchi H, Saghafi-Asl M, Ebrahimi-Mameghani M, Ostadrahimi A. Food Insecurity and Lipid Profile Abnormalities Are Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Case-Control Study. Ecol Food Nutr 2021;60:508-24. [PMID: 33573415 DOI: 10.1080/03670244.2021.1875453] [Reference Citation Analysis]
43 Han AL. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. Nutrients 2020;12:E1555. [PMID: 32471118 DOI: 10.3390/nu12061555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Uno S, Nebert DW, Makishima M. Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice. Food Chem Toxicol 2018;113:73-82. [PMID: 29366871 DOI: 10.1016/j.fct.2018.01.029] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
45 Park S, Bae JH. Probiotics for weight loss: a systematic review and meta-analysis. Nutr Res 2015;35:566-75. [PMID: 26032481 DOI: 10.1016/j.nutres.2015.05.008] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 13.0] [Reference Citation Analysis]
46 González-peña D, Dudzik D, Colina-coca C, de Ancos B, García A, Barbas C, Sánchez-moreno C. Multiplatform metabolomic fingerprinting as a tool for understanding hypercholesterolemia in Wistar rats. Eur J Nutr 2016;55:997-1010. [DOI: 10.1007/s00394-015-0914-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
47 Ziolkowska S, Binienda A, Jabłkowski M, Szemraj J, Czarny P. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:11128. [PMID: 34681787 DOI: 10.3390/ijms222011128] [Reference Citation Analysis]
48 Jia L, Jiang SM, Liu J. Behavioral gastroenterology: An emerging system and new frontier of action. World J Gastroenterol 2017; 23(33): 6059-6064 [PMID: 28970721 DOI: 10.3748/wjg.v23.i33.6059] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
49 Fakhoury-sayegh N, Trak-smayra V, Sayegh R, Haidar F, Obeid O, Asmar S, Khazzaka A. Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease. Nutrition Research 2019;62:101-12. [DOI: 10.1016/j.nutres.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
50 Riazi K, Raman M, Taylor L, Swain MG, Shaheen AA. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? Nutrients 2019;11:E2878. [PMID: 31779112 DOI: 10.3390/nu11122878] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
51 Rives C, Fougerat A, Ellero-Simatos S, Loiseau N, Guillou H, Gamet-Payrastre L, Wahli W. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020;10:E1702. [PMID: 33371482 DOI: 10.3390/biom10121702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
52 Lim HS, Choi J, Lee B, Kim SG, Kim YS, Yoo JJ. Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. Clin Nutr Res 2020;9:182-94. [PMID: 32789148 DOI: 10.7762/cnr.2020.9.3.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Black PN, Ahowesso C, Montefusco D, Saini N, DiRusso CC. Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids. Medchemcomm 2016;7:612-22. [PMID: 27446528 DOI: 10.1039/C6MD00043F] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
54 Chi-Cervera LA, Montalvo GI, Icaza-Chávez ME, Torres-Romero J, Arana-Argáez V, Ramírez-Camacho M, Lara-Riegos J. Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®). J Med Biochem 2021;40:60-6. [PMID: 33584141 DOI: 10.5937/jomb0-24689] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Jia L, Liu J. Behavioral gastroenterology and its application. Shijie Huaren Xiaohua Zazhi 2016; 24(31): 4259-4263 [DOI: 10.11569/wcjd.v24.i31.4259] [Reference Citation Analysis]
56 Nuño-Lámbarri N, Domínguez-Pérez M, Baulies-Domenech A, Monte MJ, Marin JJ, Rosales-Cruz P, Souza V, Miranda RU, Bucio L, Montalvo-Jave EE, Concepción Gutiérrez-Ruiz M, García-Ruiz C, Fernández-Checa JC, Gomez-Quiroz LE. Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice. Oxid Med Cell Longev 2016;2016:9895176. [PMID: 27635189 DOI: 10.1155/2016/9895176] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
57 Zhang H, Shen WJ, Li Y, Bittner A, Bittner S, Tabassum J, Cortez YF, Kraemer FB, Azhar S. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond) 2016;13:63. [PMID: 27708683 DOI: 10.1186/s12986-016-0121-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Sohel MMH. Macronutrient modulation of mRNA and microRNA function in animals: A review. Anim Nutr 2020;6:258-68. [PMID: 33005759 DOI: 10.1016/j.aninu.2020.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]